Skip to main content
Back to RA Capital Management

RA Capital Management's Health Care Portfolio

Browse 154 Health Care companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Health Care Companies
154
Total Funding in Health Care
$18.1B

Health Care Portfolio Companies (154)

Export
BiotechnologyHealth CareTherapeutics

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Copenhagen, Denmark
September 2025
$6.6M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncology

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

Boston, United States
September 2024
$175.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

San Diego, United States
September 2025
$100.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyDiabetesHealth CarePharmaceutical

KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.

Cambridge, United States
September 2025
$125.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyDeveloper ToolsHealth CareOncologyTherapeutics

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Wilmette, United States
September 2025
$135.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical Device

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Mountain View, United States
September 2022
$50.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

Raleigh, United States
September 2024
$1.2M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Boston, United States
September 2023
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyBusiness DevelopmentFinanceFinancial ServicesHealth CareTherapeutics

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Indianapolis, United States
September 2022
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Grove City, United States
September 2022
$90.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

San Diego, United States
September 2025
$690.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareMedicalMedical DeviceWearables

Empatica is an affective computing company focused on human data analytics.

Cambridge, United States
August 2022
$25.9M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

New Haven, United States
August 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Elder CareHealth CareHome Health CareInformation TechnologymHealth

Vesta Healthcare is a technology and clinical services organization that offers virtual care services.

New York, United States
July 2024
$10.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

South San Francisco, United States
July 2024
$175.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Boston, United States
July 2023
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

London, United Kingdom
July 2022
$4.1M
Grant

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeutics

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Del Mar, United States
July 2024
$30.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Cambridge, United States
July 2021
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Ocelot Bio brings new treatment options to patients with severe liver disease.

San Diego, United States
July 2023
$3.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Cambridge, United States
June 2026
$600.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareTherapeutics

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Waltham, United States
June 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Hamel, United States
June 2026
$500.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Boston, United States
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyHealth CareMedical

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Cambridge, United States
June 2022
$1.3B
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Aurora, United States
June 2022
$40.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeuticsWellness

Medicenna is a clinical stage, privately held, immuno-oncology company.

Toronto, Canada
June 2026
$4.4M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

San Francisco, United States
June 2026
$10.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMental HealthNeurosciencePharmaceutical

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Toronto, Canada
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMen's

Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.

Charlottesville, United States
June 2026
$92.5M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Victoria, Canada
June 2026
$3.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Austin, United States
June 2023
$210.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyTherapeutics

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Piscataway, United States
June 2026
$226.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
June 2026
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CarePharmaceutical

CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.

Boston, United States
June 2026
$10.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareMedicalMedical Device

Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.

Redwood City, United States
May 2025
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Dallas, United States
May 2026
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
$55.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Seattle, United States
May 2023
$67.8M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyTherapeutics

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

La Jolla, United States
May 2023
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceProduct Research

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Seattle, United States
May 2026
$69.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

New York, United States
May 2026
$6.8M
Post-IPO Secondary

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Cambridge, United States
May 2024
$120.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Cambridge, United States
April 2024
$130.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Durham, United States
April 2026
$5.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Cambridge, United States
April 2024
$160.5M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
$110.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$5.0M
Convertible Note

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Boulder, United States
April 2025
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Waltham, United States
April 2023
$150K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Menlo Park, United States
March 2026
$40.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.

Jersey City, United States
March 2025
$5.6M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth Diagnostics

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

London, United Kingdom
March 2023
$34.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Cambridge, United States
March 2026
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Cambridge, United States
March 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Carlsbad, United States
March 2026
$3.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Bedford, United States
March 2024
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
March 2026
$50.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

South San Francisco, United States
March 2024
$240.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyEmergency MedicineHealth Care

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

South San Francisco, United States
March 2025
$175.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

San Diego, United States
March 2024
$175.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Ovid Therapeutic's purpose is to solve intractable medical problems.

New York, United States
March 2026
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Los Altos, United States
March 2024
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Waltham, United States
March 2026
$719.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Altrincham, United Kingdom
February 2026
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareHealth DiagnosticsHospitalMedicalPrimary and Urgent CareWellness

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

Mclean, United States
February 2022
$325.0M
Series E

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceRobotics

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Pisa, Italy
February 2024
$110.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Redwood City, United States
February 2026
$50.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Palo Alto, United States
February 2026
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Newton, United States
February 2025
$200.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Copenhagen, Denmark
February 2026
$275.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CarePharmaceutical

ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

New York, United States
February 2026
$115.0M
Series D

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Boston, United States
September 2025
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareHospitalPersonal Health

Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.

Los Angeles, United States
June 2025
$26.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Boston, United States
April 2025
$59.2M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
April 2025
$9.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bambusa Therapeutics operates as biotechnology company.

Boston, United States
February 2025
$90.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalNeuroscienceWellness

We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US

Chicago, United States
November 2024
$25.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

South San Francisco, United States
November 2024
$101.0M
Series A

Founder Contacts

30,000+ verified contacts

Clinical TrialsHealth CareMedical Device

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology

Ness Ziona, Israel
October 2024
$28.5M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Philadelphia, United States
June 2024
$51.4M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Charlestown, United States
April 2024
$48.0M
Series D

Founder Contacts

30,000+ verified contacts

Health CareMedicalWellness

Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.

Greensboro, United States
October 2023
$8.0M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

San Francisco, United States
August 2023
$4.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

San Diego, United States
January 2023
$6.9M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Philadelphia, United States
January 2026
$135.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

San Carlos, United States
January 2026
$632.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Boston, United States
December 2025
$350.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

San Carlos, United States
January 2026
$1.6M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyFitnessHealth CareWellness

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Duisburg, Germany
December 2021
$98.1M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

New York, United States
December 2025
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Waltham, United States
December 2024
$30.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturing

Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.

Rio Rancho, United States
December 2025
$10.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Cambridge, United States
January 2025
$3.9M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

San Jose, United States
December 2021
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalWellness

Tasso is a Medical innovation company changing the way diagnostics are delivered

Seattle, United States
December 2021
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Belite Bio is a clinical stage biopharmaceutical drug development company.

San Diego, United States
December 2025
$350.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncology

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Irvine, United States
December 2024
$238.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

Boston, United States
December 2021
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

San Francisco, United States
December 2025
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Charlottesville, United States
January 2025
$57.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareHospitalNeuroscienceTherapeutics

Cortica provides neurological therapies for children with autism and other developmental differences.

San Diego, United States
November 2024
$80.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyPersonal Health

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

South San Francisco, United States
November 2025
$75.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Boston, United States
November 2022
$107.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

New York, United States
November 2024
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

New Haven, United States
November 2025
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Boston, United States
January 2026
$103.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareLife ScienceTherapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.

Waltham, United States
October 2025
$40.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.

San Diego, United States
October 2025
$339.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Oxford, United Kingdom
October 2024
$32.5M
Series B

Founder Contacts

30,000+ verified contacts

Health Care

Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.

Palm Beach Gardens, United States
October 2023
$50.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Cambridge, United States
October 2025
$3.6M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

Cambridge, United States
October 2021
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

San Francisco, United States
October 2023
$245.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

South San Francisco, United States
October 2023
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.

San Francisco, United States
October 2025
$183.0M
Series C

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

Laguna Hills, United States
October 2025
$19.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Shanghai, China
January 2026
$287.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Beijing, China
August 2025
$12.7M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical Device

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Kadima, Israel
July 2024
$105.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

Suzhou, China
August 2023
$100.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.

Redwood City, United States
June 2021
$15.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncology

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Wilmington, United States
May 2021
$200.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

South San Francisco, United States
March 2021
$80.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

San Diego, United States
February 2021
$135.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

San Diego, United States
December 2020
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareLife Science

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

Cambridge, United States
October 2020
$107.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Redwood City, United States
August 2020
$70.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Brisbane, United States
February 2020
$200.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

New York, United States
March 2019
$50.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Dallas, United States
February 2019
$150.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.

Arlington, United States
January 2019
$44.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .

Ballybrit, Ireland
December 2018
$30.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedical DevicePharmaceutical

We transform the management of OUD to help people begin and sustain recovery.

Plymouth Meeting, United States
January 2018
$110.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOrganic Food

Adeo Health Science is consumer health and biotechnology company, focusing on improving immune health in infants

Boston, United States
January 2018
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.

Boston, United States
June 2016
$53.8M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOrganic Food

Antera Therapeutics is creating therapies that will prevent allergy development in children.

Boston, United States
June 2016
$2.0M
Seed

Founder Contacts

30,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio